sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet
- RxCUI
- 1799212
- RxNorm name
- sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet
- Display name
- sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet
- Full name
- sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sofosbuvir and Velpatasvir | VELPATASVIR AND SOFOSBUVIR | Asegua Therapeutics LLC | d0c1a945-4440-4b5c-81aa-693ed3db597c | 2025-03-06 | Boxed warning, Warnings, Adverse reactions | 1799212 |
| Epclusa | VELPATASVIR AND SOFOSBUVIR | Gilead Sciences, Inc. | 7f30631a-ee3b-4cfe-866b-964df3f0a44f | 2024-06-05 | Boxed warning, Warnings, Adverse reactions | 1799212 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7f30631a-ee3b-4cfe-866b-964df3f0a44f | sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [PSN] · sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [SCD] | 2 | 14 | These highlights do not include all the information needed to use EPCLUSA safely and effectively. See full prescribing information for EPCLUSA. EPCLUSA ® (sofosbuvir and velpatasvir) tablets, for oral use EPCLUSA ® (sofosbuvir and velpatasvir) oral pellets Initial U.S. Approval: 2016 | 20240605 |
| d0c1a945-4440-4b5c-81aa-693ed3db597c | sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [PSN] · sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use SOFOSBUVIR and VELPATASVIR TABLETS safely and effectively. See full prescribing information for SOFOSBUVIR and VELPATASVIR TABLETS. SOFOSBUVIR and VELPATASVIR tablets, for oral use, 400 mg/100 mg (Authorized generic of EPCLUSA ® ) Initial U.S. Approval: 2016 | 20250306 |
| 996466df-f236-4804-b10f-838aa83231a1 | sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [PSN] · sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [SCD] | 2 | 6 | These highlights do not include all the information needed to use EPCLUSA safely and effectively. See full prescribing information for EPCLUSA. EPCLUSA™ (sofosbuvir and velpatasvir) tablets, for oral use Initial U.S. Approval: 2016 GILEAD ACCESS PROGRAM | 20250424 |